Cite
HARVARD Citation
Stein, R. et al. (n.d.). Serum Infliximab, Antidrug Antibodies, and Tumor Necrosis Factor Predict Sustained Response in Pediatric Crohn's Disease. Inflammatory bowel diseases. 22 (6), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Stein, R. et al. (n.d.). Serum Infliximab, Antidrug Antibodies, and Tumor Necrosis Factor Predict Sustained Response in Pediatric Crohn's Disease. Inflammatory bowel diseases. 22 (6), p. . [Online].